NATALIE GEORGEON: Open Payments
NPI 1669911327 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$847 in 7 payments from 6 companies in 2025. Trend: 2023 $211 · 2024 $17 · 2025 $847
Food & beverage: $847
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $247 |
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
| Vanda Pharmaceuticals Inc. | 1 | $124 |
| ABBVIE INC. | 1 | $123 |
| Amarin Pharma, Inc. | 1 | $122 |
| Viatris Specialty LLC | 1 | $106 |
Products named: INGREZZA, COBENFY, FANAPT, VRAYLAR, Vascepa, YUPELRI.
Industry payments across PA — which companies pay providers there.
